Open menu

Nanotechnology General News

The latest news from academia, regulators
research labs and other things of interest

Posted: September 19, 2007

ULURU Inc. to Present at UBS Global Life Sciences Conference 2007

(Nanowerk News) ULURU Inc. (Amex: ULU) announced today that Kerry P. Gray, the company's President and Chief Executive Officer, will provide a corporate presentation at the UBS Life Sciences Conference in New York, NY on September 25, 2007 at 8:30 a.m. Eastern time.
Interested investors and others may also listen to the presentation, hosted by UBS, live and by replay at http://www.ibb.ubs.com and clicking on the link for this webcast. Access to the webcast is not password protected.
About ULURU Inc.:
ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Hydrogel Nanoparticle Aggregate technology. For further information about ULURU Inc., please visit our website at http://www.uluruinc.com.
This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including but not limited to statements made relating to the value of our products in the marketplaces, our ability to develop and market our technologies, commercialization of products in the marketplace and to the future financial performance of ULURU Inc. (the "Company"). These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2006 and other reports filed by us with the Securities and Exchange Commission.
Source: Uluru Inc.